Eric I. Marks, MD
Assistant Professor
Boston University School of Medicine
Dept of Medicine
Hematology & Medical Oncology

MD, Pennsylvania State College of Medicine




2019 Brown University: Certificate of exemplary teaching
2016 Penn State Cancer Institute house-staff award for clinical performance

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Marks EI, Brown VS, Dizon DS. Am J Clin Oncol. Genomic and Molecular Abnormalities in Gynecologic Clear Cell Carcinoma. 2020; 43(2):139-145.
  2. Marks EI, Pamarthy S, Dizon D, Birnbaum A, Yakirevich E, Safran H, Carneiro B. ROS1-GOPC/FIG: a novel gene fusion in hepatic angiosarcoma. Oncotarget. 2019; 10:245-251.
  3. Marks EI, Ollila TA. Acanthocytosis causing chronic hemolysis in a patient with advanced cirrhosis. Blood. 2019; 133:1518.
  4. Lipton A, Leitzel K, Ali SM, Polimera HV, Nagabhairu V, Marks E, Richardson AE, Krecko L, Ali A, Koestler W, Esteva FJ, Leeming DJ, Karsdal MA, Willumsen N. High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts. Int J Cancer. 2018 12 01; 143(11):3027-3034. PMID: 29923614; DOI: 10.1002/ijc.31627;
     
  5. Yacur M, Marks EI, Suleski J, Joshi M. Expression of Beta-Human Chorionic Gonadotropin (BetaHCG) in Transitional Cell Carcinoma. Annals of Carcinogenesis. 2017; 2(2):1012-1016.
  6. Marks EI, Yee NS. Molecular genetics and targeted therapeutics in biliary tract carcinoma. World J Gastroenterol. 2016 Jan 28; 22(4):1335-47. PMID: 26819503
     
  7. Marks EI, Yee NS. World J of Gastroenterol. Molecular genetics and targeted therapeutics in biliary tract carcinoma. 2016; 22(4):1335-1347.
  8. Marks EI, Yee NS. Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies. World J Gastrointest Oncol. 2015 Nov 15; 7(11):338-46. PMID: 26600933
     
  9. Marks EI, Tan C, Zhang J, Zhou L, Yang Z, Scicchitano A, El-Deiry WS. Regorafenib with a fluoropyrimidine for metastatic colorectal cancer after progression on multiple 5-FU-containing combination therapies and regorafenib monotherapy. Cancer Biol Ther. 2015; 16(12):1710-9. PMID: 26561209
     
  10. Marks EI, Yee NS. World J Gastrointest Oncol. Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies. 2015; 7(333):338-346.
Showing 10 of 14 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 14 publications over 6 distinct years, with a maximum of 7 publications in 2015

YearPublications
20157
20162
20171
20181
20192
20201

Contact for Mentoring:
Marks's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Similar People
_
Same Department